Drug Induced Liver Injury Network (DILIN)

The NIDDK established a multi-center Drug Induced Liver Injury Network (DILIN) in order to develop standardized instruments to identify and fully characterize cases of drug-induced liver injury; define the epidemiology and clinical spectrum of drug-induced liver injury; and obtain biological samples for study of the pathogenesis of drug-induced liver injury using the most current biochemical, serological and genetic techniques. Support from the private sector through the FNIH enabled the NIDDK to expand and broaden the Network’s goals.

Leave a comment

Your email address will not be published. Required fields are marked *